SELLAS Life Sciences Group (SLS) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.17
-0.14
-0.1
-0.06

Details

Expected EPS
-0.105
Actual EPS
-0.07
Surprise EPS
0.03
Surprise Percent
+33.33%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.07 per share for Q2 2025.

0 Comments

Share your thoughts